Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07518238) titled 'Hernia Abd Wall Recons - BDE vs Exparel' on April 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Baylor Research Institute
Condition:
BDE for Hernia Patients
Exparel for Hernia Patients
Intervention:
Drug: BDE Injectable Drug
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: January 13, 2026
Target Sample Size: 128
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07518238
Published ...